Appendix 4. Unless otherwise specified in the Contract Documents, any reference in the Contract Documents to a Code and Standard affecting any portion of the Project shall be deemed to: (a) include all paragraphs and subparagraphs of such reference; and (b) mean the latest edition or revision thereof and amendments and supplements thereto in effect on the Effective Date.
Appendix 4. 3.4 - certification by Buyer's legal counsel specifying:
Appendix 4. 4 – Undertaking to maintain confidentiality
Appendix 4. 01.13 contains complete and faithful copies of the work and service contracts corresponding to Primary Executives, as defined below, and which are current as of this date. There are also copies of all the modifications made to them, along with a spreadsheet of the wages or fees agreed to, the services contracted and the start and end dates. To this effect, “Primary Executives” is understood to mean Rodrigo Xxx Xxxtillo, Xxxxxxxxx Xxxxxx, Diego Naxxx, Xxxxxxo Xxxx, Xxxxx Baxxxxx, Xxxxxx Bxxxxxxxxxxx, Xxxxxxo Xxxxx, Xxxxx Chxxxxxx, Xxxx Xedxx Xxxxx, Fernando Xxxx, Xxxx Xicxxxx Xxxxxxx, Jose Luix Xxxxx, Xxxxx Laxxx xxx Xxxrigo Xxxxxxxx.
Appendix 4. 3.2 - a copy of the Questionnaire, Appendix B to the Sale Procedure, including any question and/or request for details, information or additional document delivered by Seller to Buyer, and a full and complete copy of the answers given thereto by Buyer and by others, if any, including any and all appendices thereto ("QUESTIONNAIRE").
Appendix 4. 3.3 - a specification, along with certification by Controlling Shareholders' legal counsel, of:
Appendix 4. 2 of the SPA With effect from the date of this Agreement, Appendix 4.2 (Payment and Allocation of Purchase Price) of the SPA shall be replaced in its entirety with a new appendix which has been attached to this Agreement as Exhibit 4.
Appendix 4. 41 APPENDIX 5............................................................................................................................................58 APPENDIX 6............................................................................................................................................60 APPENDIX 7............................................................................................................................................62 APPENDIX 8............................................................................................................................................66 APPENDIX 9............................................................................................................................................70 APPENDIX 10..........................................................................................................................................71
Appendix 4. Re: Classification Specifications Class Definition: Positions in this grade are under general direction of a Road Xxxxxxx II or General Xxxxxxx and are responsible for carrying out assigned leadhand functions relating to their respective classification.
Appendix 4. Financial Arrangements The financial arrangements for the clinical trial should be appended as Appendix 4 of the PC-mCTAs. Sponsors and Trial Sites should use the NIHR interactive Costing Tool (iCT) to derive a contract value, in line with the nation-specific processes of the UK nation in which the Trial Site is established. The financial and other interests of universities that might employ the medical academics and sometimes the research fellows and research nurses involved in clinical trials should be recognised by Trial Sites. The notification arrangements noted above are designed to ensure that universities have the information needed for the protection of their interests. There should be formal agreement between Trial Sites and universities, covering their entire clinical trials portfolio, setting out processes for the identification of the university’s direct and indirect costs and overheads, and the apportioning of research income between the institutions. This issue could be covered in the partnership agreements between Trial Sites and associated academic institutions that are negotiated in the process of implementing research governance arrangements. In the case of clinical trials for which the investigator’s or site team members’ substantive contract is held by a university, the university should be involved in the calculation of staff costs for the trial and the NHS primary care independent contractor should agree the content of the financial schedule with the university. Appendix 4 should be populated with details of the financial arrangements of the clinical trial and it should not be used for other matters. There should not be separate financial arrangements between the Sponsor and a university that employs an investigator. The staging or scheduling of payments should be negotiated, including any payments to be made before administration of the Investigational Drug(s), or any other clinical intervention mandated by the protocol, (for example, site set-up costs) and whether such payments are refundable or non-refundable. Clinical trials are undertaken by Trial Sites under income generation rules and are commercial services supplied under contract to companies. Invoicing arrangements should be via the Trial Site’s finance officer, practice manager or equivalent, using formal VAT invoices in compliance with NHS Standing Financial Instructions.
